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Frequency and Use of Medications
in Horses Racing at Prairie Meadows
Debra M. Sime*; Richard L. Engen, PhD**
and Peggy Miller-Graber, PhD***
Department of Veterinary Physiology and Pharmacology
College of Veterinary Medicine
Iowa State University
An analysis was made of the horses racing at Prairie Meadows race track in Altoona, Iowa
during 1993 to determine the number of entries designated as racing under the influence of
phenylbutazone (Bute(RX)), furosemide (Lasix(Rx)) or both medications. In a total of 1379 Quarter Horse
entries, 5.7 % raced with no medication, 74.9 % raced on phenylbutazone, 0.5 % raced on furosemide,
and 18.9 % raced on both phenylbutazone and furosemide. In a total of 3424 Thoroughbred entries,
2.1 % raced under no medication, 43.6 % raced on phenylbutazone, 0.4 % raced on furosemide, and
53.9 % raced on both phenylbutazone and furosemide. Overall, of the 4803 entries, 3.2 % raced with
no medication, 52.6 % raced on phenylbutazone, 0.4 % raced on furosemide, and 43.9 % raced on
both phenylbutazone and furosemide.
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Introduction
In the racing industry, two medications
are consistently used, phenylbutazone (Bute(Rx))
and furosemide (Lasix(Rx)). These two medications
are highly regulated by state racing commissions,
and their adrninistration to racing horses, prior to
and during a race day, must comply with state rac-
ing rules.
Phenylbutazone is a non-steroidal anti-
inflammatory agent that acts by inhibiting pros-
taglandin synthesis, which in turn will decrease an
inflammatory response. Specifically,
phenylbutazone inhibits the enzyme,
cyclooxygenase, which is needed for platelet 'func-
tion and clotting action2• In Iowa, racing regula-
tions state that phenylbutazone may not be ad-
ministered to a horse in dosages that would result
in concentrations of more than 2.2 ug/ml of
phenylbutazone or its metabolites in the blood.
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This restriction prohibits the administration of
phenylbutazone to any entered horse on a race
day. In addition, if a horse is to race with
phenylbutazone in its system, the trainer must
designate on the entry that the horse will race un-
der the influence of phenylbutazone medication.
The information is then placed after the horse's
name on the racing card4 •
Furosemide is a diuretic that is routinely
used as a prophylactic medication for exercise-
induced pulmonary hemorrhage (EIPH). Exercise-
induced pulmonary hemorrhage is a pulmonary
vasculature disorder found in over 50 - 70 % of
horses performing strenuous exercise and is char-
acterized by bleeding in the respiratory tract origi-
nating from the lung. A horse that exhibits EIPH
is generally termed a "bleeder"6. In accordance
with Iowa racing regulations, furosemide is admin-
istered to a bleeder four hours prior to the sched-
uled race, at a dose of 250 mg. When a horse
races under the influence of furosemide, that in-
formation must be noted behind the horse's name
on a racing card4 •
The etiology of EIPH is still unknown, as
well as the mechanism of action for furosemide's
prevention or reduction in severity of an EIPH epi-
sode. Two studies have shown that furosernide
can reduce right atrial and pulmonary pressures
of horses during exercise2,5. It was also found that
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when furosenlide was administered in addition to
cyclooxygenase inhibitors, specifically
phenylbutazone or flunixin meglumine, this reduc-
tion in right atrial and pulmonary pressures was
reversed. Therefore, the study concluded that
furosemide may reduce or prevent an EIPH epi-
sode by mediating some of its effects through the
cylooxygenase pathway2.
The objective of this study was to deter-
mine the number of horses racing under the influ-
ence of medication, specifically phenylbutazone
and furosemide. A second objective was to deter-
mine the number of horses that exhibited an EIPH
episode while racing under the influence of
'furosemide medication.
Materials and Methods
Data was obtained for each day of the
1993 60-day race meet at Prairie Meadows race
track in Altoona, Iowa, from the Daily Racing Form1•
The number of entered horses was separated into
categories designated as racing on no medication,
racing on phenylbutazone, racing on furosemide,
or racing on both phenylbutazone and furosenlide.
The information was based on the notation of
medication use, found on the racing card behind
each horse's name. Information concerning
whether a horse bled through furosemide during
a race was obtained from the Iowa State track vet-
erinarian.
Results
Our analysis found that there were a to-
tal of 4,803 horses entered in 549 races during
the 1993 racing season. Of the 4,803 horses,
3,424 horses were Thoroughbreds\and 1,379
horses were Quarter Horses. The race meet con-
sisted of 141 Quarter Horse races, 399 Thorough-
bred races and 9 Thoroughbred and Quarter Horse
mixed races for a total of 549 races.
It was determined that of the 3,424 Thor-
oughbred entries, 2.1 % raced with no medication,
43.6 % raced on phenylbutazone, 0.4% raced on
furosemide, and 53.9% raced on both
phenylbutazone and furosemide. It was also de-
termined that 0.30/0, 36.7%, 0.3°10 and 62.7% of
the winning horses in the Thoroughbred races,
raced using no medication, phenylbutazone,
furosemide, and phenylbutazone and furosemide,
respectively.
Of the 1379 entered Quarter Horses, it
was determined that 5.7% raced with no medica-
tion, 74.90/0 raced on phenylbutazone, 0.5°10 raced
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on furosemide, and 18.9% raced on both
phenylbutazone and furosemide. In the 9 Thor-
oughbred and Quarter Horse mixed races, the
winning horse was a Quarter Horse. Therefore,
3.3%, 65.8%, .6% and 30.3% of the Winning Quar-
ter Horses raced using no medication,
phenylbutazone, furosemide, and phenylbutazone
and furosemide, respectively.
During the racing season, 3°1o of the
Quarter Horses and 0.40/0 of the Thoroughbred
horses medicated with furosemide bled during a
race. This amounted to eight Quarter Horses and
seven Thoroughbreds bleeding through
furosemide during a race, as reported by Dr. Gor-
don, Iowa State track veterinarian3 • Of the Quar-
ter Horses, one horse bled during a race while
racing on phenylbutazone, before being medicated
'vvith fUiosemide. The hOise subsequently bled
again while racing on 'furosemide, and during both
races, placed no greater than sixth. Of the re-
maining seven Quarter Horses, one horse placed
first but was disquali'fied and placed eighth, three
horses placed second, one horse placed third, one
horse placed fifth and one horse placed eighth.
All eight of the Quarter Horses that bled through
the furosemide medication were also racing on
phenylbutazone. All of the seven Thoroughbreds
that bled while racing on furosemide were also
racing on phenylbutazone. Of the seven Thor-
oughbreds, one horse 'finished first, one horse fin-
ished fifth, two horses finished sixth, one horse
finished eighth, one horse finished tenth, and one
horse did not 'finish. In addition, two other horses
bled while racing. One horse was racing on no
medication and finished 'fifth, the other horse was
racing on phenylbutazone and finished seventh.
Conclusion
From this study, it was determined that if
a horse was determined to be a bleeder and rac-
ing on furosemide medication, the 110rse would
almost always race on phenylbutazone. It was
also determined, based on the winning horse of a
race, a Quarter Horse racing on phenylbutazone
or a Thoroughbred racing on phenylbutazone and
furosemide performed better than the horses in
the other medication categories or racing on no
medication. Overall, 97.5% of the Thoroughbred
racing at Prairie Meadows during the 1993 racing
season were medicated with phenylbutazone and
54.30/0 were medicated with furosemide, while
93.8% of the Quarter Horses were medicated with
phenylbutazone and 20.4% were medicated with
furosemide. This study suggests that more re-
Iowa State Veterinarian
search needs to be conducted concerning the ef-
fect racing medications have on exercising horses.
In addition, it needs to be determined whether the
use of phenylbutazone in conjunction with
furosemide in EIPH horses helps prevent the oc-
currence of an EIPH episode or if the use of
phenylbutazone predispose a horse to becoming
a bleeder.
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